Onyx Biotec (NSE:ONYX) Total Liabilities: ₹397.5 Mil (As of Mar. 2026)


NSE:ONYX Onyx Biotec Ltd NSE:ONYX
13 GF Score
Price ₹38.60
! 6 Warning Signs
View Full Analysis

What is Onyx Biotec Total Liabilities?

Onyx Biotec NSE:ONYX +4.89% 13 Total Liabilities is ₹397.5 Mil as of Mar. 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review.

Onyx Biotec's Total Liabilities for the quarter that ended in Mar. 2026 was ₹397.5 Mil.

Onyx Biotec's quarterly Total Liabilities increased from Mar. 2025 (₹356.26 Mil) to Sep. 2025 (₹374.02 Mil) and increased from Sep. 2025 (₹374.02 Mil) to Mar. 2026 (₹397.47 Mil).

Onyx Biotec's annual Total Liabilities declined from Mar. 2024 (₹488.48 Mil) to Mar. 2025 (₹356.26 Mil) but then increased from Mar. 2025 (₹356.26 Mil) to Mar. 2026 (₹397.47 Mil).

Onyx Biotec Total Liabilities Historical Data

* Premium members only.

The historical data trend for Onyx Biotec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Biotec Total Liabilities Chart

Onyx Biotec Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
204.63 405.22 488.48 356.26 397.47

Onyx Biotec Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial 488.48 0.00 356.26 374.02 397.47
NSE:ONYX
13GF Score
Onyx Biotec Ltd NSE:ONYX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Biotec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Onyx Biotec's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=325.27+(46.894+25.304
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=397.5

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=951.546-554.078
=397.5

Onyx Biotec's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=325.27+(46.894+25.304
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=397.5

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=951.546-554.078
=397.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹397.5 Mil mean?
Onyx Biotec (NSE:ONYX) has a Total Liabilities of ₹397.5 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Onyx Biotec and its competitors.
Is Onyx Biotec's Total Liabilities too high?
Onyx Biotec's current Total Liabilities is ₹397.5 Mil. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Total Liabilities compare to ISRG and BDX?
Onyx Biotec's Total Liabilities of ₹397.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Onyx Biotec and its competitors. Onyx Biotec's current Total Liabilities is ₹397.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Total Liabilities of ₹397.5 Mil. The current Total Liabilities is ₹397.5 Mil. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Total Liabilities is ₹397.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onyx Biotec Business Description

Address Nalagarh Road, Near Sainimajraropar, Village Bir Plassi, Solan, HP, IND, 174101
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score

Get the complete analysis for NSE:ONYX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹38.60
Price